Re-engaging lapsed patients without being intrusive
Re-engaging lapsed patients works when it is treated as care continuity, not a sales campaign. Define lapse against a follow-up the doctor expected, segment carefully, suppress anyone who should not hear from you, write in the treating team’s voice, cap frequency across every team, make booking effortless, and prove impact against a holdout group rather than counting replies.
Every hospital has a second patient base it never markets to. It sits in the HIS and the CRM: people who came for a consultation, a procedure or a health check, were looked after, and then simply stopped showing up. Some recovered. Some moved city. Some went to the clinic nearer home. And some were meant to come back for a review and never did, because nobody made it easy.
Re-engaging lapsed patients is one of the most commercially sensible things a hospital can do, and one of the easiest to get wrong. Done badly, it reads like a telecom company chasing a lapsed subscription. Done well, it feels like the hospital remembered you and made the next step simple. The difference is not the channel or the software. It is the judgement about who you contact, why, when, and with whose voice.
What follows is how I think about building this as a programme rather than a campaign, with the guardrails that keep it on the right side of patients, doctors and the DPDP Act.
Why lapsed patients are a different audience
A new patient is making a choice. A lapsed patient has already made one, and then made another by not returning. That second choice was rarely a verdict on the hospital. In my experience it is mostly friction: the review date was vague, the follow-up call never came, the parking was a nightmare, the doctor moved to another unit, or the report came on WhatsApp and the conversation ended there.
This matters for tone. You are not persuading a stranger. You are resuming a relationship that has gone quiet, with someone who already knows your building, your billing desk and perhaps your food. They will judge any message against that memory. If their memory is good, a thoughtful nudge lands well. If it is mixed, a cheerful promotional message makes it worse.
It also matters for economics. Acquiring a fresh patient in a competitive catchment means paying search engines, aggregators and referral intermediaries. A returning patient costs a message, a call and a slot. But only if the return is genuine. Pushing people back who have no reason to come creates empty appointments, no-shows and irritation, which is its own cost.
Define lapsed before you contact anyone
Most re-engagement efforts start with a list pulled on a Friday afternoon: everyone who has not visited in a long while. That list is useless. It mixes a person who had a one-off fever consultation years ago with a diabetic patient who used to come every quarter and vanished. Those two people need entirely different handling, and one of them should probably not be contacted at all.
I prefer to define lapse relative to an expected return, not relative to the calendar. If the treating doctor documented a review, or the care pathway implies one, then a patient is lapsed when that expected visit passes without a booking. If there was no expected return, the patient is not lapsed. They are simply a past patient, and you treat them as part of your general audience, not as someone who owes you a visit.
This definition needs clinical input to set, but it does not need clinical judgement from marketing. Sit with the medical director and the heads of the high-volume specialties and agree, specialty by specialty, which encounters carry a natural return. Cardiology and endocrinology will have many. Orthopaedic post-operative follow-up will have a clear sequence. Emergency visits and one-time diagnostics usually will not. Write the rules down, and let the CRM apply them.
The segments that deserve different handling
Once the definition is agreed, a small number of segments usually covers most of the value. Each gets its own message, owner and cadence.
- Missed reviews: patients whose documented follow-up date has passed. Highest value, most sensitive, and the one where the treating doctor’s name matters most.
- Incomplete journeys: people who were advised a procedure or a further investigation, discussed estimates, and went quiet. These need a counsellor, not a campaign.
- Annual and preventive returns: health check customers and chronic patients whose annual review is due. Lower sensitivity, higher volume, well suited to automation.
- Relationship lapses: families who used the hospital across generations and have stopped. A service recovery conversation is often more useful here than any offer.
- Do not contact: deceased patients, patients who withdrew consent, patients with open complaints or legal matters, and anyone flagged by the treating team. This list must be checked before every send.
The last segment is the one people forget. Nothing damages a hospital faster than a cheerful health check reminder reaching the family of a patient who died in its ICU. That is not a hypothetical risk. It is what happens when the mortality flag lives in one system and the campaign tool reads from another.
Re-engaging lapsed patients without being intrusive
Intrusiveness is mostly about three things: relevance, frequency and voice. Get relevance right and patients tolerate a lot. Get it wrong and even one message feels like surveillance.
Relevance means the message refers to something the patient would recognise as theirs. “Your review with the cardiology team was due last month” is relevant. “Get a full body check at a special price” is not, if the person came for a knee. At the same time, relevance has a ceiling. Do not name a diagnosis in a WhatsApp preview or an SMS that anyone in the household can read. Refer to the department or the doctor, and let the detail sit behind a login or a phone call.
Frequency should be capped at the patient level, across every team. The contact centre, the health check sales team, the pharmacy and the marketing team can each believe they are sending a reasonable number of messages, while the patient receives all of them. A single contact policy owned in the CRM, with a hard cap and a quiet period after any clinical event, prevents that.
Voice is the most underrated lever. Messages in the name of the treating doctor’s team, written plainly, in the patient’s preferred language, feel like care. Messages in the name of the brand, with exclamation marks and offers, feel like marketing. For missed reviews, I would always choose the former, with the doctor’s agreement on the wording.
Consent, DPDP and the doctor’s name
The DPDP Act has made hospitals look again at how they use patient contact details, which is healthy. The practical position I work to is simple: the patient should have been told, clearly and at a sensible moment, that the hospital may contact them about their follow-up care and related services, and should have an easy way to stop it. Care reminders tied to their own treatment sit more comfortably with that expectation than promotions for unrelated services.
That suggests a hierarchy. Follow-up reminders about the patient’s own care are the core. Preventive and annual reminders come next, with clear opt-out. Offers for new services come last and need explicit permission. Your legal and compliance teams should set the exact lines, but marketing should arrive with this hierarchy already drafted, because it shapes everything downstream.
Using a doctor’s name is a separate permission. Doctors are rightly protective of how their name appears in patient communication. Agree templates with them in advance, show them exactly what goes out, and give them the ability to exclude specific patients. Most doctors welcome a well-run follow-up programme because it protects continuity of care. What they object to is discovering their name on a message they never saw.
If you are building the underlying system from scratch, it is worth reading what a hospital CRM is actually for before you configure a single journey. Re-engagement is one of the clearest tests of whether the CRM has been set up as a patient relationship system or as a lead dump.
Channel and sequence: a quiet cadence
The sequence I recommend for missed reviews is deliberately gentle. A first message on the patient’s preferred channel, usually WhatsApp in most Indian cities, in the doctor’s team’s voice, with a direct way to book. If there is no response after a reasonable gap, a phone call from a trained care coordinator, not a sales agent. If there is still no response, stop. Log the attempt, and let the patient come back on their own terms.
Two touches and a call is usually enough. More than that and you are chasing. The call is where most of the value sits, because it is the only point where you find out why the person stopped coming. Sometimes the answer is that they are fine. Sometimes they have gone elsewhere and are happy. Sometimes they had a bad experience nobody knew about. That last group is gold, because a service recovery conversation can win back the family, not just the patient.
For health checks and annual returns, automation does most of the work, and that is appropriate. The piece on what healthcare marketing automation actually replaces goes further into which of these touches a machine can own and which still need a person. The rule of thumb: the more personal the reason for contact, the more human the channel should be.
Making the return easy once they say yes
Many re-engagement programmes succeed at getting a reply and then fail at the booking. The patient says yes on WhatsApp and is told to call the switchboard. The switchboard cannot see the conversation. The preferred doctor has no slots for three weeks. The patient gives up again, now slightly more annoyed than before.
Before you send a single message, check the path from reply to confirmed appointment. The coordinator handling replies should see the patient’s history, the treating doctor’s availability and any open estimate or complaint. They should be able to book, reschedule and send directions in the same conversation. If the treating doctor has left, the coordinator needs a script for introducing a colleague in the same department, agreed with that department.
Capacity matters here as well. A well-run re-engagement push can fill a follow-up clinic that was already busy, and new patients then wait longer. Plan the sends against slot availability, specialty by specialty, rather than blasting the whole list in one week. The same thinking applies to any demand you create; the argument in capacity is a marketing constraint holds just as strongly for returning patients.
Measuring it without fooling yourself
The easy metric is replies. It is also the wrong one. What you care about is the proportion of lapsed patients in each segment who return for an honoured appointment within a sensible window, compared with a similar group you did not contact. Without that comparison, you will credit the programme with people who were going to come back anyway.
A holdout group is not complicated. Leave a small random slice of each segment uncontacted for a cycle and compare return rates. It feels wasteful for the first month. It saves years of arguing about whether the programme works. It also protects you from the finance team’s fair question, which is how much of this revenue would have arrived regardless.
Track the negative signals too. Opt-outs, complaints, blocked numbers and angry calls to the unit head are all data about intrusiveness. If they rise after a change in wording or frequency, reverse the change. A re-engagement programme that brings people back but also generates one-star reviews about spam is costing more than it shows.
What I would do in the first six weeks
Start with one specialty that has clear follow-up rules and a supportive head of department. Cardiology or diabetes care often works. Agree the lapse definition with the doctors, write the do-not-contact rules with the medical records team, and get consent language cleared by compliance. That is the first fortnight, and it is mostly conversations.
In the next fortnight, build the segment in the CRM, test the do-not-contact checks against real records, and draft the messages in the doctor team’s voice in the languages your patients actually use. Brief and train the coordinators who will take replies and make the calls. Set up the holdout group before anything is sent.
In the final fortnight, send in small batches matched to clinic capacity, listen to every reply for the first week, and fix the wording based on what patients say back. Review opt-outs and complaints weekly with the department head. Only when that specialty is running quietly and the doctors are comfortable should you add the next one. Slow expansion is what keeps this from turning into the kind of messaging patients learn to ignore.
Questions people ask
It is the structured practice of contacting past patients who were expected to return for follow-up or ongoing care and have not, and making it easy for them to come back. It is different from general marketing to past patients, because it is anchored to an expected return agreed with doctors, uses the patient’s own care as the reason for contact, and respects consent, frequency caps and do-not-contact rules throughout.
Because returning patients already trust the unit and cost far less to bring back than strangers acquired through paid media or intermediaries. Missed reviews also represent continuity of care gaps that doctors care about. The case is strongest when you treat it as a care continuity programme with a commercial benefit, not as a revenue campaign, because that framing keeps doctors supportive and patients comfortable.
By comparing the return rate of contacted patients against a random holdout group in the same segment that received no contact. The difference between the two is the incremental effect. Without a holdout, the programme will claim credit for patients who would have returned anyway. I would agree the holdout design with finance before launch so the result is trusted by both sides.
It depends on what the patient was told and agreed to, which is why compliance must set the lines. In practice, reminders about the patient’s own follow-up care sit on firmer ground than promotions for unrelated services. Hospitals should have clear notice, an easy opt-out on every message, and records of consent that the CRM checks before any send. Legal advice should settle specifics.
You should see and approve every template that carries your name or your team’s name before it is used. A good programme also lets you exclude specific patients, keeps diagnoses out of message previews, and routes clinical questions from patients back to your team rather than answering them through marketing. If any of that is missing, you are entitled to ask for it before agreeing.
Deceased patients and their families about routine services, anyone who has withdrawn consent or opted out, patients with open complaints or legal matters, and anyone the treating team has flagged. The do-not-contact list should be checked automatically before every send, drawing on medical records, the complaints system and consent records, not maintained by hand in a spreadsheet.
For most Indian urban patients, a WhatsApp message on an approved business account is the most natural first touch, followed by a phone call from a trained coordinator if there is no reply. SMS works as a fallback. Email rarely matters except for corporate and international patients. The more personal the reason for contact, the more the channel should involve a real person.
Fewer than most teams think. Two written touches and one phone call, spaced sensibly, is usually enough for a missed review. After that, stop and log the attempt. Frequency should be capped at the patient level across every team in the hospital, so the pharmacy, health check desk and marketing are not each sending their own reasonable number of messages to the same person.
A reliable feed from the HIS into the CRM showing encounters, documented follow-up dates, doctor and department, plus flags for mortality, consent status and complaints. IT also needs to ensure the messaging platform reads the same consent and do-not-contact data as the CRM. Most failures in this area come from two systems holding different versions of the truth about a patient.
Trained care coordinators or patient relationship staff, not sales agents on targets. The call is where you learn why the patient stopped coming, and that requires listening rather than pitching. Coordinators need access to history, doctor availability and open estimates, a script for introducing another doctor if the original has left, and a clear route to escalate complaints to service recovery.
A single specialty pilot can usually be running within about six weeks if the CRM has reasonable data. Most of that time goes into agreeing definitions with doctors, clearing consent language and testing do-not-contact rules, not into building journeys. Expanding to further specialties is faster once the rules and templates exist, but each new department still needs its own doctor agreement.
You can, but I would be cautious. A discount reframes a care conversation as a sale and can make patients question the original advice. For missed reviews, ease of booking and a message from the doctor’s team matter far more than price. Offers are more appropriate for preventive health checks, where the patient understands they are buying a package.
Watch opt-outs, blocked numbers, complaints, negative reviews that mention messaging, and angry calls to the unit head. Track them per segment and per template. If any of them rises after a change in wording or cadence, reverse the change. Listening to replies in the first week of each new batch is also one of the best early warnings you will get.
Ask them to show patient-level frequency caps across all campaigns, automatic suppression from consent and do-not-contact data, templates in regional languages, reply handling that lands with a named coordinator, and holdout group support in reporting. Ask to see these working on realistic data, not described on slides. If the tool cannot suppress reliably, nothing else it does matters.
